Abstract
Prior to the AIDS epidemic, malignant lymphomas, in particular non-Hodgkin’s lymphoma (NHL), were described in up to 30% of the patients with primary immunodeficiency disorders such as the X-linked lymphoproliferative syndrome or the Wiscott Aldrich syndrome. Moreover, patients with immune deficiency secondary to cytostatic anticancer therapy and also following organ transplantation, autoimmune diseases and connective tissue disorders are at increased risk of NHL The lymphomas which arise in all these settings and in patients with HIV infection have certain features in common, including 1) prevalence of high-grade pathological types, predominantly large cell and immunoblastic lymphomas, or small non-cleaved cell; 2) restriction to B-cell origin; 3) widely disseminated disease at presentation; 4) poor prognosis compared to patients with “common” lymphomas.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ziegler JL, Beckstead JA, Volberding PA et al: Non-Hodgkin lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 1984 (311):565–570
Knowles DM, Chamulak GA, Subar M et al: Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1987). Ann Intern Med 1988 (108): 744–753
Lowenthal DA, Straus DJ, Campbell SW et al: AIDS-related lymphoid neoplasia. The Memorial Hospital experience. Cancer 1988 (61):2325–2337
Kaplan LD, Abrams Dl, Feigal E et al: AIDS-asso-ciated non-Hodgkin’s lymphoma in San Francisco. JAMA 1989 (261):719–724
Roithmann S, Toledano M, Tourani JM et al: HIV-associated non-Hodgkin’s lymphomas: clinical characteristics and outcome. The experience of the French Registry of HIV-associated tumors. Ann Oncol 1991 (2):289–295
Levine AM, Sullivan-Halley J, Pike MC et al: Human immunodeficiency virus-related lymphoma - prognostic factors predictive of survival. Cancer 1991 (68):2466–2472
Pedersen C, Gerstoft J, Lundgren JD et al: HIV-associated lymphoma - histopathology and association with Epstein-Barr virus genome related to clinical, immunological and prognostic features. Eur J Cancer 1991 (27):1416–1423
Gill P, Levine A, Krailo M et al: AIDS-related malignant lymphoma: results of prospective treatment trials. J Clin Oncol 1987 (5): 1322–1328
Monfardini S, Tirelli U, Vaccher E et al: Malignant lymphomas in patients with or at risk for AIDS. JNCI 1988 (80):855–860
Levine AM, Wernz JC, Kaplan L et al: Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective, multi-institutional trial. JAMA 1991 (266):84–88
Levine A: Epidemiology, clinical characteristics and management of AIDS-related lymphoma. Hemat/ Onc Clin of North Amer 1991 (2):331
Pluda J, Broder S, Yarchoan R: Therapy of AIDS and AIDS-associated neoplasms. In: Pinedo HM, Longo DL and Chabner BA (eds) Cancer Chemotherapy and Biological Response Modifiers Annual 13. Elsevier Science Publishers BV, Amsterdam 1992 pp 395–439
Northfelt D and Kaplan LD: Clinical aspects of AIDS-related non-Hodgkin’s lymphoma. Curr Opin Oncol 1991 (3):872–880
Boyle M, Swanson CE, Turner JJ et al: Definition of two distinct types of AIDS-associated non-Hodgkin lymphoma. Br J Haem 1990 (76):506–512
Biggar RJ, Horm J, Goedert JJ, Melbye M: Cancer in a group at risk of acquired immunodeficiency syndrome (AIDS) through 1984. Am J Epidemiol 1987 (126):578–586
Goldstein J, Dickson DW, Moser FG et al: Primary central nervous system lymphoma in acquired immune deficiency syndrome. Cancer 1991 (67): 2756–2765
Ziegler JL: “Biologic” differences in acquired immune deficiency syndrome-associated non-Hodgkin’s lymphomas? J Clin Oncol 1991 (8): 1329–1331
Kalter SP, Riggs SA, Cabanillas F et al: Aggressive non-Hodgkin’s lymphomas in immunocompromised homosexual males. Blood 1985 (3):655–659
Bermudez MA, Grant KM, Rodvien R, Mendes F: Non-Hodgkin’s lymphoma in a population with or at risk for acquired immunodeficiency syndrome: Indication for intensive chemotherapy. Am J Med 1989 (86):71–76
Monfardini S, Vaccher E, Foà R, Tirelli U: AIDS-associated non-Hodgkin’s lymphoma in Italy: intravenous drug users versus homosexual men. Ann Oncol 1990 (1):203–211
Sawka CA, Shepherd FA, Brandwein J, Burkers RL, Sutton D, Warner E: Treatment of AIDS-related non-Hodgkin’s lymphoma with a twelve week chemotherapy program. Leukemia and Lymphoma 1992 (8):213–220
Matsushima Y, Kanzawa F, Hoshi A: Time-schedule dependency of the inhibiting activity of various anticancer drugs in the clonogenic assay. Cancer Chemother Pharmacol 1985 (14):104–107
Sparano JA, Wiernik PH, Strack M, Leaf A, Becker N, Valentine ES: Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus and human T-cell leukemia virus type I-related non-Hodgkin’s lymphoma: a highly active regimen. Blood 1993 (10):2810–2815
Taillan B, Garnier G, Ferrari E et al: MACOP-B chemotherapy for the treatment of high-grade lymphomas in patients with HIV-1 infection. Acta Haematol 1993 (89): 10–12
Lopez TM, Hagemeister FB, McLaughlin P et al: Small noncleaved cell lymphoma in adults: superior results for stages l-lll disease. J Clin Oncol 1990 (4):615–622
Straus DJ, Wong GY, Liu J et al: Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt’s type) in American adults: results with treatment designed for acute lymphoblastic leukemia. Am J Med 1991 (90):328
Coiffier B, Gisselbrecht C, Herbrecht R et al: LNH-84: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J Clin Oncol 1989 (7):1018–1026
Gisselbrecht C, Oksenhendler E, Tirelli U et al: Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. Am J Med 1993 (95): 188–196
Tirelli U, Errante D, Oksenhendler E et al: Prospective study with combined low-dose chemotherapy and zidovudine in 37 patients with poorprognosis AIDS-related non-Hodgkin’s lymphoma. Ann Oncol 1992 (3):843–847
Huhn D, Weiss R, Nerl C et al: HIV-related non-Hodgkin’s lymphoma: CHOP-induction and AZT/IFa-maintenance therapy. Proc ASCO 1993 (12):52 (abstract #12)
Levine AM, Katz-Willson E, Espina B et al: Low dose m-BACOD with concomitant dideoxyctidine (ddC) in AIDS related lymphoma. Blood 1992 (80/1 suppl 1): 328a (abstract #1301)
Kaplan LD, Kahn JO, Crowe S et al: Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin’s lymphoma: results of a randomized trial. J Clin Oncol 1991 (6):929–940
Walsh C, Wernz JC, Levine A et al: Phase I trial of m-BACOD and granulocyte macrophage colony stimulating factor in HIV-associated non-Hodgkin’s lymphoma. JAIDS 1993 (6):265–271
Hahn SM, Pluda J, Shay L et al: Treatment of AIDS-related non-Hodgkin’s lymphoma (NHL) with chemotherapy, AZT, and granulocyte-macrophage colony-stimulating factor (GM-CSF). VII International Conference on AIDS, Florence 16–21 June, 1991, p 274 (abstract WB 2368)
Tirelli U, Errante D, Vaccher E et al: Treatment of HIV-related non-Hodgkin’s lymphoma (NHL) with chemotherapy (CT) and G-CSF: reduction of hospitalization and toxicity with concomitant overall reduction in the cost. Proc ASCO 1993 (12):53 (abstract # 13)
Formenti SC, Gill PS, Lean E et al: Primary central nervous system lymphoma in AIDS: results of radiation therapy. Cancer 1989 (63):1101–1107
Baumgartner JE, Rachlin JR, Beckstead JH et al: Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 1990 (73):206–211
Remick SC, McSharry JJ, Wolf BC et al: Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin’s lymphoma. J Clin Oncol 1993 (9):1691–1702
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Tirelli, U., Vaccher, E. (1995). Malignant Lymphomas in Immunocompromised Hosts, in Particular with AIDS. In: Pangalis, G.A. (eds) Malignant Lymphomas: Biology and Treatment. ESO Monographs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79913-6_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-79913-6_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79915-0
Online ISBN: 978-3-642-79913-6
eBook Packages: Springer Book Archive